Overcoming Passive Cardiovascular Device Challenges with Computational Modeling and Simulation
While passive cardiovascular implants might look simple on the outside, they are challenging to develop, manufacture, and implant. These devices must function under different physiological conditions while sustaining performance throughout their intended life cycle and work for a variety of patient demographics. They also must undergo rigorous regulatory approval before reaching the market.
With so many variables, it is easy for production and regulatory approval processes to be delayed, which ultimately postpones access to these lifesaving devices for those who need them most. Computational modeling and simulation (CM&S) offers a solution to address these challenges by enabling medical device manufacturers to accelerate product development and approval while reducing uncertainty and maintaining safety.
Read the e-book to learn how in silico solutions address some of the most common challenges manufacturers face while developing passive cardiovascular devices.
